Shattering the STIGMA: Talking openly about MOUD in 12-step recovery programs

Area of Science:

• Addiction Medicine
• Recovery Science
• Public Health

Background:

• Stigma against Medications for Opioid Use Disorder (MOUD) persists in some 12-step recovery communities, such as Alcoholics Anonymous (AA) and Narcotics Anonymous (NA).
• This perspective challenges the notion that MOUD is incompatible with sobriety, despite evidence supporting its effectiveness in treating substance use disorders (SUDs).
• Historical ambivalence toward psychiatric medications in AA's founding literature and contemporary NA literature contribute to this ongoing stigma.

Purpose of the Study:

• To explore the tension between life-saving pharmacologic interventions (MOUD) and traditional 12-step fellowship beliefs.
• To examine the origins and contemporary manifestations of stigma against MOUD within recovery communities.
• To advocate for a renewed interpretation of fellowship principles that incorporates evidence-based treatment and individual recovery paths.

Main Methods:

• A clinically grounded, narrative-driven, first-person perspective.
• Examination of historical AA literature and contemporary NA literature regarding medication use and the term "clean."
• Analysis of personal experiences as physicians and individuals in long-term recovery.

Main Results:

• MOUD is stigmatized despite proven effectiveness in reducing cravings, relapse, and overdose deaths.
• Resistance to MOUD is often reinforced by sponsors, literature, and group norms within 12-step programs.
• This resistance places patients at risk and undermines the recovery process.

Conclusions:

• Stigma against MOUD in recovery communities poses a significant barrier to evidence-based treatment.
• A renewed interpretation of 12-step principles is needed to embrace MOUD and affirm diverse recovery pathways.
• True sobriety should not necessitate choosing between life-saving medication and community belonging.